The Prognostic Value of Pre-treatment Hemoglobin (Hb) in Patients With Advanced or Metastatic Gastric Cancer Treated With Immunotherapy

The Prognostic Value of Pre-treatment Hemoglobin (Hb) in Patients With Advanced or Metastatic Gastric Cancer Treated With Immunotherapy

BackgroundBiomarkers such as prevailing PD-L1 expression and TMB have been proposed as a way of predicting the outcome of immunotherapy in patients with advanced gastric cancer (AGC) and metastatic gastric cancer (MGC). Our study aims to investigate whether there is a link between pretreatment hemog...

Full description

Bibliographic Details
Main Authors: Miaomiao Gou, Yong Zhang, Tiee Liu, Tongtong Qu, Haiyan Si, Zhikuan Wang, Huan Yan, Niansong Qian, Guanghai Dai
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Oncology
Subjects:
gastric cancer
immunotherapy
hemoglobin
prognostic bio-marker
PMS
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.655716/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.655716/full

Similar Items